CanadaErythromycin Ophthalmic Ointment USP (erythromycin 5 mg/g, DIN 02326663), lot 2024L02, sold nationally in Canada is affected. It was recalled because the sterility of the product could be compromised; verify if your product is the affected lot, consult your healthcare provider before discontinuing use or for health concerns, contact Steri‑Med Pharma Inc. with questions, and report any side effects or other safety complaints to Health Canada.
What's being recalled
Depth of recall: Retailers
Companies: Steri-Med Pharma inc., 242, Rue Saint-Cyrille, Upton, QC, J0H 2E0.
How to identify it
Product Name: ERYTHROMYCIN OPHTHALMIC OINTMENT USP; Market Authorization: DIN 02326663; Dosage Form: Ointment; Strength: Erythromycin 5 mg/g; Lot numbers: 2024L02
The hazard
The sterility of the product could be compromised in the affected lot.
What to do
Verify if your product is affected.
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Contact the recalling firm if you have any questions about the recall.
Report any health product related side effects to Health Canada.
Report any other health product safety complaints to Health Canada.
Where it was sold
National
The official notice
This page is a summary of the notice published by Health Canada, collected from Health Canada, CFIA and Transport Canada. Check the original before you act on it.
Read the official notice (opens in a new tab)